CAS
NNVC icon

CTC Alternative Strategies’s NanoViricides NNVC Stock Holding History

CTC Alternative Strategies’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-605
Closed -$38.7K – 248
2014
Q1 		$38.7K Buy
+605
New +$51.7K 0.02% 150

Other funds holding NNVC

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return

CTC Alternative Strategies's NNVC Position: Q2 2014 in Review

CTC Alternative Strategies sold out of NanoViricides (NNVC) in Q2 2014, closing a stake of 605 shares — an estimated $38.7K sold.

CTC Alternative Strategies first reported a position in NNVC in Q1 2014 and held it in 1 quarter. The position peaked at $38.7K in Q1 2014. 57 funds tracked by Wall St. Rank hold NNVC as of Q2 2014.

  • CTC Alternative Strategies reported no remaining NanoViricides position as of Q2 2014 after selling out during the quarter.
  • CTC Alternative Strategies sold 605 NanoViricides shares in Q2 2014, an estimated $38.7K.
  • CTC Alternative Strategies first reported a position in NanoViricides in Q1 2014 and held it in 1 quarter.
  • CTC Alternative Strategies's NanoViricides position peaked at $38.7K in Q1 2014.
  • 57 funds tracked by Wall St. Rank held NanoViricides as of Q2 2014.

Based on CTC Alternative Strategies's 13F filing for Q2 2014, filed 22 Jul 2014.